Ascendis Pharma A/S

Common Name

Ascendis Pharma

Country

Denmark

Sector

Healthcare

Industry

Biotechnology

Employees

1,017

Ticker

ASND

Exchange

NASDAQ/NGS

Website

ascendispharma.dk

Description

Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to cre... Show more

Income Statement Balance Sheet Group Entities

Ascendis Pharma's Financial Statements Preview

Below are the financial statements of Ascendis Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of EUR	2024	2023
Revenue	363.64^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	266.72^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Cost of sales	-44.26^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-44.4^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Gross profit	319.38^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	222.32^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Research and development costs	-307^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-413.45^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Selling, general and administrative expenses	-291.14^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-264.41^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Operating profit/(loss)	-278.76^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-455.54^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Share of profit/(loss) of associates	-20.06^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-18.4^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Finance income	25.61^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	43.86^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Finance expenses	-100.03^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-44.07^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Profit/(loss) before tax	-373.24^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-474.14^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Income taxes (expenses)	-4.84^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-7.3^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Net profit/(loss) for the year	-378.08^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-481.45^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial
Attributable to owners of the company	-378.08^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial	-481.45^a Trace this value back to its sources Source traceability is available with an active trial or subscription. Start your 30-day free trial to view source references. No credit card required. Start Free Trial

Limited Data Preview

You are viewing a limited preview of Ascendis Pharma’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).

Access Datasets, Disclosures, and Sources

pro

Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.

Download granular datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace all values back to their original sources

Start Your 30-Day Free Trial

Formats Included

Excel

CSV

Json

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Ascendis Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ascendis Pharma’s data sources below and access millions more through our Disclosure Search.

a. Ascendis Pharma's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Ascendis Pharma A/S

Ascendis Pharma's Financial Statements Preview

Ascendis Pharma's Financial Statements Preview

Verified Sources Behind Ascendis Pharma’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Genmab A/S

GN Store Nord A/S

H Lundbeck A/S

Ambu A/S

Demant A/S

Novo Nordisk A/S